Royce & Associates’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Buy
123,530
+26,509
+27% +$1.44M 0.08% 376
2026
Q1
$3.74M Buy
97,021
+52,010
+116% +$2.16M 0.04% 504
2025
Q4
$2.09M Buy
+45,011
New +$2.17M 0.02% 583

Other funds holding HNGE

Royce & Associates's HNGE Position: Q2 2026 in Review

Royce & Associates increased its Hinge Health (HNGE) stake by 27% in Q2 2026, buying an estimated $1.44M and bringing the position to 123,530 shares worth $10.3M. The position accounts for 0.08% of the portfolio, ranked #376.

Royce & Associates first reported a position in HNGE in Q4 2025 and has held it in 3 quarters since. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Royce & Associates held 123,530 shares of Hinge Health worth $10.3M as of Q2 2026.
  • Royce & Associates bought 26,509 Hinge Health shares in Q2 2026, an estimated $1.44M.
  • Hinge Health made up 0.08% of Royce & Associates's portfolio in Q2 2026, its #376 holding.
  • Royce & Associates first reported a position in Hinge Health in Q4 2025 and has held it in 3 quarters since.
  • 276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.